Inventor
John Sapienza
Inventor
Chula Vista, CA, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes26%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium12%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%
PatentTitleYear
10,683,298Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors202010,618,883Antiproliferative compounds, and their pharmaceutical compositions and uses202010,227,325Antiproliferative compounds, and their pharmaceutical compositions and uses201910,167,290Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors20199,938,254Antiproliferative compounds, and their pharmaceutical compositions and uses20189,783,505'Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith'20179,771,371'Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors'20179,556,126'Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith'20179,193,692'Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors'20159,156,798'Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith'20159,079,900'Methods of synthesis and purification of heteroaryl compounds'20158,907,087'Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors'20148,569,494'Methods of synthesis and purification of heteroaryl compounds'20138,507,492'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway'20138,492,381'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway'20138,383,634'Methods of treatment using heteroaryl compounds and compositions thereof'20138,372,976'Methods of treatment comprising the administration of heteroaryl compounds'20138,299,056'Aminotriazolopyridines, compositions thereof, and methods of treatment therewith'20128,110,578'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway'20128,101,588'Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith'20127,981,893'Heteroaryl compounds, compositions thereof, and methods of treatment therewith'20117,968,556'Heteroaryl compounds, compositions thereof, and methods of treatment therewith'20117,723,340'Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith'20107,220,771'Methods of using indazole derivatives as JNK inhibitors'20077,211,594'Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith'20077,208,513'Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith'20076,897,231'Indazole derivatives as JNK inhibitors and compositions and methods related thereto'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2020Based in Chula Vista, CA, US· patent location history
2007–2020Patents assigned to SIGNAL PHARM LLC (23)· patent assignee history
2012–2013Patents assigned to SAPIENZA JOHN (6)· patent assignee history
2012–2013Patents assigned to ELSNER JAN (5)· patent assignee history
2012–2013Patents assigned to PACKARD GARRICK (5)· patent assignee history
2012–2013Patents assigned to PAPA PATRICK (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SIGNAL PHARM LLC | 23 | 2007–2020 |
| SAPIENZA JOHNself | 6 | 2012–2013 |
| ELSNER JAN | 5 | 2012–2013 |
| PACKARD GARRICK | 5 | 2012–2013 |
| PAPA PATRICK | 5 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Chula Vista, California, US | 27 | 2005–2020 |